Fortress Biotech Execs Buy Big in Zero‑Cash Grant, Sending a “Buy” Signal to Volatile Market
Fortress Biotech insiders buy 475k shares at no cash cost, signaling confidence amid volatility; investors should watch for upcoming milestones that could lift the price.
2 minutes to read